author-photo

Rebecca Auer

Queen Mary University of London

69

Papers

2611

Citations

Citation Trend

Filter By

Papers (49) Sort By

Journal Conference Others

Clinical Outcome of Coronavirus Disease 2019 in Haemato-oncology Patients.

2020 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (53)
How I treat advanced Hodgkin lymphoma - a global view.

2020 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (1)
Ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma: extended 3.5-year follow-up from a pooled analysis

2019 Haematologica
Show All
- Source
- Cite
- Save
Citations (44)
Ibrutinib for Treating Waldenström’s Macroglobulinaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal

2019 PharmacoEconomics
Show All
- Source
- Cite
- Save
Citations (0)
Randomized Phase 2 Zanubrutinib (BGB-3111) + Obinutuzumab Vs Obinutuzumab Monotherapy in Patients with Relapsed/Refractory Follicular Lymphoma (R/R FL)

2019 Blood
Show All
- Source
- Cite
- Save
Citations (2)
Correction: Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma

2019 Leukemia
Show All
- Source
- Cite
- Save
Citations (1)
Genomic profiling reveals spatial intra-tumor heterogeneity in follicular lymphoma

2018 Leukemia
Show All
- Source
- Cite
- Save
Citations (52)
Median 3.5-Year Follow-up of Ibrutinib Treatment in Patients with Relapsed/Refractory Mantle Cell Lymphoma: A Pooled Analysis

2017 Blood
Show All
- Source
- Cite
- Save
Citations (7)
Overall survival outcomes in patients with mantle-cell lymphoma (MCL) treated with Ibrutinib in a pooled analysis of 370 patients from 3 international open-label studies

2016 Haematologica
Show All
- Source
- Cite
- Save
Citations (4)
Characteristics of human primary mantle cell lymphoma engraftment in NSG mice.

2016 British Journal of Haematology
Show All
- Source
- Cite
- Save
Citations (4)